These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2181914)

  • 21. The molecular basis of secondary hyperparathyroidism in chronic renal failure.
    Rahamimov R; Silver J
    Isr J Med Sci; 1994 Jan; 30(1):26-31. PubMed ID: 8138394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical study of concerning factors of decreased bone mineral content in hemodialysis patients].
    Kohara N
    Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):587-96. PubMed ID: 1920939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New PTH assays and renal osteodystrophy.
    Salusky IB; Jüppner H
    Pediatr Nephrol; 2004 Jul; 19(7):709-13. PubMed ID: 15173936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aluminum bone content in dialysis osteodystrophy with secondary hyperparathyroidism.
    Pizzarelli F; Ballanti P; Costantini S; Mocetti P; Giordano R; Della Rocca C; Fabrizi F; Bonucci E; Maggiore Q
    Miner Electrolyte Metab; 1988; 14(2-3):129-34. PubMed ID: 3380068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
    Kaczirek K; Prager G; Riss P; Wunderer G; Asari R; Scheuba C; Bieglmayer C; Niederle B
    Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of whole PTH assay and 1-84/non-(1-84) PTH ratio in patients on hemodialysis or undergoing parathyroidectomy.
    Kato Y; Yamaguchi S; Yachiku S; Fujisawa M; Kawakami N
    Hinyokika Kiyo; 2004 Nov; 50(11):755-62. PubMed ID: 15628534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone disease in renal failure. Clinical and histomorphometric studies.
    Nilsson P
    Scand J Urol Nephrol Suppl; 1984; 84():1-68. PubMed ID: 6393322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation of serum parathyroid hormone level with other parameters of secondary hyperparathyroidism in renal insufficiency].
    Loew H; Hrubesch M; Meermann R
    Med Welt; 1976 Nov; 27(47):2272-4. PubMed ID: 1004171
    [No Abstract]   [Full Text] [Related]  

  • 29. Disorders of calcium metabolism at various times after renal transplantation.
    Babarykin D; Adamsone I; Amerika D; Folkmane I; Rozental R
    Ann Transplant; 1999; 4(1):46-53. PubMed ID: 10850601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical evaluation of osteocalcin in chronic hemodialysis patients].
    Nishio S; Hayashi S; Yoshihara H; Kobayagawa H
    Hinyokika Kiyo; 1989 Nov; 35(11):1839-45. PubMed ID: 2618881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of early renal osteodystrophy.
    Eke FU; Winterborn MH; Robertson PW
    Child Nephrol Urol; 1988-1989; 9(1-2):33-7. PubMed ID: 3251619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary hyperparathyroidism in chronic renal failure.
    Wills MR; Savory J
    Ann Clin Lab Sci; 1981; 11(3):252-61. PubMed ID: 6264838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total and regional bone mineral density by dual photon absorptiometry in patients on maintenance hemodialysis.
    Asaka M; Iida H; Entani C; Fujita M; Izumino K; Takata M; Seto H; Sasayama S
    Clin Nephrol; 1992 Sep; 38(3):149-53. PubMed ID: 1395168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia].
    Morio K; Koide K
    Nihon Rinsho; 1995 Apr; 53(4):958-64. PubMed ID: 7752492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chronic renal insufficiency and secondary hyperparathyroidism in rats. Biochemical and histological evaluation].
    Virgós MJ; Menéndez-Rodríguez P; Serrano M; González-Carcedo A; Braga S; Cannata JB
    Rev Esp Fisiol; 1993 Dec; 49(4):241-7. PubMed ID: 8209101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vitamin A status of patients with chronic renal failure in relation to renal osteodystrophy].
    Stein G; Abendroth K; Kokot F; Keil E; Schöne S; Wessel G; Fünfstück R; Sperschneider H
    Z Urol Nephrol; 1985 Mar; 78(3):159-65. PubMed ID: 4002896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis.
    Raggi P; James G; Burke SK; Bommer J; Chasan-Taber S; Holzer H; Braun J; Chertow GM
    J Bone Miner Res; 2005 May; 20(5):764-72. PubMed ID: 15824849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cultures of human osteoblastic cells from dialysis patients: influence of bone turnover rate on in vitro selection of interleukin-6 and osteoblastic cell makers.
    Sánchez MC; Bajo MA; Selgas R; Mate A; Sánchez-Cabezudo MJ; López-Barea F; Esbrit P; Martínez ME
    Am J Kidney Dis; 2001 Jan; 37(1):30-37. PubMed ID: 11136164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcitriol may directly suppress bone turnover.
    Ureña P; Prieur P; Pétrover M
    Nephron; 1997; 75(1):116-7. PubMed ID: 9031288
    [No Abstract]   [Full Text] [Related]  

  • 40. [Renal osteodystrophy(II)].
    Covic A; Florea L; Ungureanu C; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(4):21-5. PubMed ID: 12089954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.